Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease An Observational Pilot Study

YILDIRIM H., METİNTAŞ M., ENTOK E., AK G., AK SİVRİKOZ İ., DÜNDAR E., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.4, sa.12, ss.1480-1484, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 12
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1097/jto.0b013e3181c0a7ff
  • Dergi Adı: JOURNAL OF THORACIC ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1480-1484
  • Anahtar Kelimeler: F-18-fluorodeoxyglucose positron emission tomography-computed, tomography, Asbestos, Pleural disease, Malignant mesothelioma, Diffuse pleural thickening, Benign asbestos-related pleural effusions, PET, CT, DIAGNOSIS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background: Several studies have already addressed the potential role of an increased fluorine 18 fluorodeoxyglucose (F-18 FDG) uptake in identification of pleural malignancy. In this pilot study, we investigate the role of F-18-FDG positron emission tomography/computed tomography (PET/CT) for differentiating asbestos-related benign pleural disease from malignant mesothelioma.